Mark McClellan MD, PhD

Mark McClellan


Mark McClellan, MD, PhD


PhD, Massachusetts Institute of Technology

MD, Harvard Medical School

MPA, Harvard University

BA, University of Texas at Austin

Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University. With offices in Durham, NC and Washington, DC, the Duke-Margolis Center is a university-wide, interdisciplinary initiative that is nationally and internationally recognized for its research, evaluation, implementation, and educational initiatives to improve health and health policy. The Center integrates Duke’s expertise in the social, clinical, and analytical sciences with health care leader and stakeholder engagement to develop and apply policy solutions that improve health and the value of health care locally, nationally, and worldwide.

Dr. McClellan is a physician and an economist who has informed and improved a wide range of strategies and policy reforms to advance health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership.

With highly distinguished record in public service and academic research, Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These reforms include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. He previously served as a member of the President’s Council of Economic Advisers, senior director for health care policy at the White House, and Deputy Assistant Secretary for Economic Policy at the Department of the Treasury.

Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the FDA and a member of the National Academy of Medicine (NAM), where he chairs the Leadership Council for Value and Science-Driven Health care, co-chairs the guiding committee of the Health Care Payment Learning and Action Network, and is a research associate at the National Bureau of Economic Research. He is also a Senior Advisor on the faculty of the University of Texas Dell Medical School, co-chair of the Accountable Care Learning Collaborative, and a member of the Healthtech 4 Medicaid Board of Directors. Dr. McClellan is also an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and Seer. He was previously an associate professor of economics and medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.

Lopez MH, Daniel GW, Fiore NC, Higgins A, McClellan MB. Paying For Value From Costly Medical Technologies: A Framework For Applying Value-Based Payment Reforms. Health Affairs (Project Hope). 2020 Jun;39(6):1018–25.

McClellan MB, Bleser WK, Joynt Maddox KE. Advancing Value-Based Cardiovascular Care: The American Heart Association Value in Healthcare Initiative. Circulation Cardiovascular Quality and Outcomes. 2020 May 12;13(5):e006610.

Joynt Maddox K, Bleser WK, Crook HL, Nelson AJ, Hamilton Lopez M, Saunders RS, et al. Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative's Value-Based Models Learning Collaborative. Circulation Cardiovascular Quality and Outcomes. 2020 May 12;13(5):e006483.